Literature DB >> 27811627

Provider, Patient, and Practice Factors Shape Hepatitis B Prevention and Management by Primary Care Providers.

Nizar A Mukhtar1, Priya Kathpalia, Joan F Hilton, Gene Lau, Albert Yu, Kevin Grumbach, Tung T Nguyen, Daniel Chan, Mandana Khalili.   

Abstract

GOALS: To evaluate provider knowledge, attitudes and barriers to hepatitis B virus (HBV) care and management practices across diverse primary care settings.
BACKGROUND: Factors influencing adherence to recommended HBV screening and management guidelines are poorly defined.
MATERIALS AND METHODS: Providers across various health care settings in San Francisco were surveyed. Multivariate analyses were used to identify factors associated with recommended HBV screening, vaccination, and disease monitoring.
RESULTS: Of 277 (41.3%) responding providers, 42% reported performing HBV screening in >50% of at-risk patients, and 49%, HBV vaccination in >50% of eligible patients. Most reported appropriate monitoring of a majority of HBV-infected patients with alanine aminotransferase (79%) and HBV viral load (67%) every 6 to 12 months, but performed any hepatocellular carcinoma screening in 49%. Provider factors significantly associated with HBV screening were speaking an Asian language [odds ratio (OR), 3.27], offering HBV treatment (OR, 3.00), having >25% of Asian patients in practice (OR, 2.10), practicing in safety net settings (OR, 7.51) and having higher barrier score (OR, 0.74). Appropriate HBV monitoring was associated with provider speaking an Asian language (OR, 3.43) and provider age (OR, 0.68/decade). Hepatocellular carcinoma screening was associated with having >25% of patients speaking English as a second language (OR, 4.26) and practicing in safety net settings (OR, 0.14).
CONCLUSIONS: Rates of adherence to HBV guidelines were suboptimal irrespective of practice setting and were influenced by certain provider, patient and practice factors. This study reinforces the importance of engaging primary care providers in development, dissemination, and implementation of evidence-based HBV practice guidelines.

Entities:  

Mesh:

Year:  2017        PMID: 27811627      PMCID: PMC5413438          DOI: 10.1097/MCG.0000000000000738

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  22 in total

1.  Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease.

Authors:  Hashem El-Serag; Katherine A McGlynn; Garth N Graham; Samuel So; Charles D Howell; Ted Fang; Janelle Tangonan Anderson; Thelma King Thiel
Journal:  J Fam Pract       Date:  2010-04       Impact factor: 0.493

2.  Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care.

Authors:  Blaire E Burman; Nizar A Mukhtar; Brian C Toy; Tung T Nguyen; Alice Hm Chen; Albert Yu; Peter Berman; Hali Hammer; Daniel Chan; Charles E McCulloch; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2013-09-20       Impact factor: 3.199

3.  Suboptimal surveillance for and knowledge of hepatocellular carcinoma among primary care providers.

Authors:  Christopher E McGowan; Teresa P Edwards; Mai-Uyen T Luong; Paul H Hayashi
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-10       Impact factor: 11.382

4.  A comprehensive screening and treatment model for reducing disparities in hepatitis B.

Authors:  Henry Pollack; Su Wang; Laura Wyatt; Chia-Hui Peng; Kejia Wan; Chau Trinh-Shevrin; Kay Chun; Thomas Tsang; Simona Kwon
Journal:  Health Aff (Millwood)       Date:  2011-10       Impact factor: 6.301

5.  Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

Authors:  M-F Yuen; H-J Yuan; D K-H Wong; J C-H Yuen; W-M Wong; A O-O Chan; B C-Y Wong; K-C Lai; C-L Lai
Journal:  Gut       Date:  2005-05-04       Impact factor: 23.059

6.  Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994.

Authors:  G M McQuillan; P J Coleman; D Kruszon-Moran; L A Moyer; S B Lambert; H S Margolis
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

7.  Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.

Authors:  Cindy M Weinbaum; Eric E Mast; John W Ward
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

8.  Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response.

Authors:  Samali Lubega; Uchenna Agbim; Miranda Surjadi; Megan Mahoney; Mandana Khalili
Journal:  Liver Int       Date:  2013-03-20       Impact factor: 5.828

9.  Hepatitis B in the Greater San Francisco Bay Area: an integrated programme to respond to a diverse local epidemic.

Authors:  R G Gish; S L Cooper
Journal:  J Viral Hepat       Date:  2010-12-08       Impact factor: 3.728

10.  San Francisco hep B free: a grassroots community coalition to prevent hepatitis B and liver cancer.

Authors:  Meredith B Bailey; Rita Shiau; Janet Zola; Susan E Fernyak; Ted Fang; Samuel K S So; Ellen T Chang
Journal:  J Community Health       Date:  2011-08
View more
  14 in total

Review 1.  Barriers to Disease Monitoring and Liver Cancer Surveillance Among Patients with Chronic Hepatitis B in the United States.

Authors:  Simona Ispas; Samuel So; Mehlika Toy
Journal:  J Community Health       Date:  2019-06

2.  Reducing Liver Cancer Risk in African-Born Immigrants Through Culturally Targeted Hepatitis B Group Education Programs.

Authors:  Kemi Bolutayo; Alexandre Ly van Manh; Noah Cohen; Daouda Ndiaye; Lina Jandorf; Ponni V Perumalswami
Journal:  J Cancer Educ       Date:  2018-12       Impact factor: 2.037

3.  Mortality in adults with chronic hepatitis B infection in the United States: a population-based study.

Authors:  Kali Zhou; Jennifer L Dodge; Joshua Grab; Eduard Poltavskiy; Norah A Terrault
Journal:  Aliment Pharmacol Ther       Date:  2020-05-20       Impact factor: 8.171

Review 4.  Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping Review.

Authors:  Eliza W Beal; Mackenzie Owen; Molly McNamara; Ann Scheck McAlearney; Allan Tsung
Journal:  J Gastrointest Cancer       Date:  2022-07-26

5.  Health Within Reach-a Patient-Centered Intervention to Increase Hepatitis B Screening Among Asian Americans: a Randomized Clinical Trial.

Authors:  Mandana Khalili; Nicole J Kim; Janice Y Tsoh; Judith M E Walsh; L Elizabeth Goldman; Ginny Gildengorin; Ching Wong; Mi T Tran; Edgar Yu; Michael Thanh Sharp; Vivian H LeTran; Vi-Van Nguyen; Tung T Nguyen
Journal:  J Gen Intern Med       Date:  2022-01-06       Impact factor: 6.473

Review 6.  Epidemiology and Prevention of Tuberculosis and Chronic Hepatitis B Virus Infection in the United States.

Authors:  Amit S Chitnis; Ramsey Cheung; Robert G Gish; Robert J Wong
Journal:  J Immigr Minor Health       Date:  2021-06-23

7.  A Patient-Centered Hepatitis B Virus (HBV) Educational Intervention Improves HBV Care Among Underserved Safety-Net Populations.

Authors:  Robert J Wong; Mandana Khalili
Journal:  J Clin Gastroenterol       Date:  2020-08       Impact factor: 3.174

8.  Hepatitis B virus outreach to immigrant population in Greater Boston Area: Key to improving hepatitis B knowledge.

Authors:  Raissa Djoufack; Scarlett Se Yun Cheon; Aisha Mohamed; Fatou Faye; Korka Diouf; Richard Colvin; James Morrill; Ann-Marie Duffy-Keane; Ponni Perumalswami; Gonzague Jourdain; Dahlene Fusco
Journal:  World J Gastroenterol       Date:  2017-11-14       Impact factor: 5.742

9.  Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey.

Authors:  Nizar A Mukhtar; Donna M Evon; Colina Yim; Anna S Lok; Nadra Lisha; Mauricio Lisker-Melman; Mohamed Hassan; Harry L A Janssen; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2020-04-01       Impact factor: 3.199

10.  High Prevalence of Cirrhosis at Initial Presentation Among Safety-Net Adults with Chronic Hepatitis B Virus Infection.

Authors:  Elaine Tang; Sharon Torres; Benny Liu; Rachel Baden; Taft Bhuket; Robert J Wong
Journal:  J Clin Exp Hepatol       Date:  2017-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.